Abstract The importance of Glucagon like peptide 1 (GLP-1) for metabolic control and insulin release sparked the evolution of genes mimicking GLP-1 action in venomous species (e.g
Acetil-L-Carnitina, Acetyl Carnitine, Actyl Carnitine, Acetyl L-Carnitine, Actyl-L-Carnitine, Acetyl-L-Carnitine Arginate Dihydrochloride, Acetyl-L-Carnitine Arginate HCl, Actyl-L-Carnitine Arginate HCl, Acetyl-L-Carnitine HCl, Actyl-L-Carnitine HCl, Acetyl L-Carnitine Hydrochloride, Acetyl Carnitine, Actyl-Carnitine, Acetyl-Levocarnitine, Actyl-Lvocarnitine, ALC, Alcar, Carnitine Acetyl Ester, Dihydrochlorure dActyl-L-Carnitine Arginate, Gamma-Trimethyl-Beta-Acetylbutyrobetaine, L-Acetylcarnitine, L-Actylcarnitine, Levacecarnine, N-Acetyl-Carnitine, N-Actyl-Carnitine, N-Acetyl-L-Carnitine, N-Actyl-L-Carnitine, ST-200, Vitamin B(t) Acetate, 2-(acetyloxy)-3-carboxy-N,N,N-trimethyl-1-propanaminium inner salt
Some individuals who meet strict clinical criteria can acquire GLP1 (Wegovy (semaglutide) and GIP Mounjaro (tirzepatide) from the NHS, but many get them privately from approved weight management clinics or online businesses
The Danish company Novo Nordisk sells several different brand names with semaglutide as an active ingredient: notably, Ozempic, for diabetes and reducing cardiovascular event risks, and Wegovy, for weight loss and reducing cardiovascular event risks